迷走右锁骨下动脉:胎儿与新生儿异常及遗传学筛查或检测异常的相关性
回顾性分析79例产前诊断迷走右锁骨下动脉(ARSA)胎儿,其中48例接受染色体评估,7例为21三体,4例其他核型异常,所有遗传学异常胎儿均合并其他超声异常发现;43例孤立性ARSA胎儿新生儿结局均无异常,未发现22q11.2缺失。结论认为孤立性ARSA为良性,不增加21三体或22q11.2缺失风险,但ARSA发现需行详细胎儿超声检查。
要点
- 孤立性ARSA胎儿未见21三体或22q11.2缺失, neonatal outcomes均无异常。
- 所有合并遗传学异常的ARSA胎儿均存在其他超声异常发现。
- 产前发现ARSA应行详细胎儿超声检查以排查合并异常。
核心结论
- 孤立性ARSA为良性发现,与21三体或22q11.2缺失无关;但发现ARSA需行详细胎儿超声检查,因为所有合并遗传学异常的胎儿均有其他超声异常发现。
研究设计与样本
- 回顾性病历回顾,纳入产前诊断ARSA的胎儿79例,孕周20.3±3.8周;数据来自胎儿解剖筛查、胎儿超声心动图、无创21三体筛查项目、侵入性遗传学检测及新生儿记录。
关键影像表现/征象
- 79例胎儿中48例接受染色体评估,7例为21三体,4例其他异常核型。
- 所有遗传学异常胎儿均合并其他超声异常发现。
- 3例自发胎死宫内(21三体2例,Wolf-Hirschhorn综合征1例),9例因异常终止妊娠,1例死于左心发育不良综合征。
- 43例为孤立性ARSA,新生儿结局均无异常,出院后6个月内无再入院。
- 未发现或怀疑新生儿存在22q11.2缺失。
临床应用与阅片要点
- 产前发现ARSA时,应行详细胎儿超声检查以评估是否合并其他异常。
- 孤立性ARSA胎儿的新生儿结局良好,未见21三体或22q11.2缺失。
局限性
- 本文为回顾性病历回顾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether fetuses with an isolated aberrant course of the right subclavian artery (ARSA) have increased risk for chromosomal abnormalities, including trisomy 21 or 22q11 deletion.
METHODS: We performed a retrospective chart review of all fetuses with antenatally diagnosed ARSA. Data were collected from fetal anatomic surveys, fetal echocardiograms, noninvasive trisomy 21 screening programs, invasive genetic studies, and neonatal records.
RESULTS: Seventy-nine fetuses with ARSA were identified at 20.3 ± 3.8 weeks' gestation. Forty-eight fetuses underwent chromosomal evaluation. Of those, seven had trisomy 21. Four other fetuses had unusual karyotype abnormalities. All fetuses with genetic anomalies had additional aberrant ultrasound findings. There were three spontaneous fetal deaths (trisomy 21-2 and Wolf-Hirshhorn-1). Nine pregnancies were terminated because of abnormalities and one died as a result of hypoplastic left heart syndrome. No neonate was found or suspected to have 22q11.2 deletion. The ARSA was isolated in 43 fetuses; all had unremarkable neonatal outcomes, and none were readmitted within 6 months after discharge.
CONCLUSIONS: As an apparently isolated finding, ARSA is benign and not associated with trisomy 21 or 22q11.2 deletion. The finding of ARSA, however, warrants a detailed fetal ultrasound. All fetuses with ARSA and genetic anomalies had additional ultrasound findings.
引用
- Ranzini AC, Hyman F, Jamaer E, et al. Aberrant Right Subclavian Artery: Correlation Between Fetal and Neonatal Abnormalities and Abnormal Genetic Screening or Testing. J Ultrasound Med. 2017. PMID: 28072476. doi:10.7863/ultra.16.05028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。